MIDI is pleased to attend Advanced Therapies Week, hosted by Phacilitate, in Dallas from January 20–23, 2025.
This event serves as an important platform for exploring the future of advanced therapies and discussing innovative solutions shaping the industry. We’ll be sharing insights into our advanced bioprocessing instrumentation, disposables, and system architecture expertise and how we help organizations achieve their therapeutic development goals efficiently and effectively.
Let’s Connect!
We’re eager to meet with attendees during the event to discuss opportunities for collaboration and innovation. Visit our Bioprocessing Expertise Page to learn more and schedule a meeting with our team.
We look forward to connecting with you in Dallas!
MIDI will be attending J.P. Morgan Healthcare Conference Week in San Francisco, January 13–16, 2025!
In addition to the J.P. Morgan Healthcare Conference, you’ll find us at these premier events:
These gatherings provide incredible opportunities to engage in strategic discussions and explore innovative solutions to the challenges and opportunities shaping the MedTech and Biotech industries in 2025.
At MIDI, we’re proud to showcase our proven development processes that drive innovation, helping clients efficiently transform groundbreaking technologies into advanced, market-ready solutions.
Let’s Connect! Email Gregm@midipd.com or message on LinkedIn
If you’re attending any of these events, we’d like to meet with you to discuss how we can collaborate on advancing MedTech innovation. Together, we can shape the future of the industry.
Just in time for Advanced Therapies Week, MIDI is proud to announce a new addition to our website showcasing our expertise in bioprocessing engineering for cell and gene therapies.
This page highlights how MIDI is driving innovation with advanced instrumentation, disposables, and system architectures designed to support next-generation, automated, closed-system therapies. With our proprietary DevelopmentDNA™ methodology, we streamline workflows, eliminate cold-chain dependencies, and enable scalable, point-of-care manufacturing solutions.
Whether you’re navigating FDA QSR, ISO 13485, or combination product requirements, or scaling from lab prototypes to commercial production, MIDI is your trusted partner.
Visit the Expertise Page to learn more about how we can help you pioneer transformative therapies.
MIDI—where biopharma innovation meets unmatched expertise in product development.
We do not share your information with third parties
